Meeting a deadline Congress set for a report assessing the US infant formula supply chain and identifying potential solutions to vulnerabilities didn’t stop criticism of the Food and Drug Administration not only from lawmakers, but also from its former food policy chief.
On the same day the agency published “a national strategy outlining actions” for ensuring consistent supply of formula, including specialty products, a subcommittee of the House Oversight Committee made clear...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?